Latest News- Phage Therapy Market: Escherichia coli is expected to lead the Product segment during 2024-2028

The Phage Therapy Market is being driven by Benefits of phage therapy over antibiotics

The Phage Therapy Market is expected to grow at a CAGR of 17.41% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 51 million. Phage therapy, an emerging alternative to conventional antibiotics, is garnering significant investment due to the global health concern over antibiotic-resistant bacteria. In a recent development, AMR Action Fund and Deerfield Management have committed an initial USD12 million, with plans to raise a total of USD30 million, in a Series B1 round for Adaptive Phage. This investment will support the clinical advancement of Adaptive Phage's pipeline of phage therapeutics, designed to combat antimicrobial resistance (AMR) infections, addressing a pressing public health challenge. 

Get more information on Phage Therapy Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Escherichia coli
  • Staphylococcus aureus
  • Salmonella
  • Others
• Application
  • Animal health
  • Food industry
  • Others
• Geography
  • Europe
    • UK
  • North America
    • Canada
    • US
  • Asia
    • China
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Benefits of phage therapy over antibiotics
• Increasing application of phage therapy for animal health
• Increasing application of phage therapy for human health

However, the market also witnesses some limitations, which are as follows:

• High quality and safety requirements for phage preparations
• Evolution of bacterial resistance to phages
• High regulatory control for phage therapy

Benefits of Buying Global Phage Therapy Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Phage Therapy Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Phage therapy encompasses various applications of bacteriophages, or phages, in diverse fields. These include Lysogenic Phages for host bacterial transformation, Phage Display for producing peptides and proteins, Phage-Mediated Gene Delivery for genetic manipulation, Phage-Based Diagnostics for pathogen detection, and Phage Biocontrol Agents for combating bacterial infections. Furthermore, Phage-Derived Peptides and Enzymes have therapeutic potential, while Phage-Based Nanomaterials offer advancements in materials science. Phage-Based Biofilms, Bioremediation, and Biocontrol are used in environmental applications, and Phage-Mediated Bioremediation, Biopesticides, and Biosensors are employed in agriculture and food safety. Phage-Based Antibacterial Coatings, Water Treatment, Food Preservation, Wound Healing, Immunotherapy, Vaccines, Probiotics, and Personalized Medicine are some of the healthcare applications. Phage-Based Synthetic Biology, Genome Editing, CRISPR-Cas Systems, Bioengineering, Biomaterials, Tissue Engineering, Regenerative Medicine, Bioprinting, Nanotechnology, and Nanomedicine are advanced research areas. Phage-Based Precision Medicine, Targeted Therapy, and Bioprinting are personalized approaches to healthcare, while Phage-Based Environmental Remediation and Agricultural Applications address ecological concerns. Overall, phage therapy holds immense potential in various industries and scientific disciplines.

Market Research Overview

The Phage Therapy Market is a significant segment of the global Pharmaceuticals industry, which encompasses entities involved in the research and development (R&D) or manufacturing of various pharmaceutical offerings, including generic and non-generic drugs, veterinary medicines, and now, lytic phages, phage cocktails, phage engineering, phage biomanufacturing, and phage delivery solutions. Technavio, a leading global technology research and consulting firm, sizes the healthcare market based on the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the global Pharmaceuticals market is anticipated to be fueled by factors such as the increasing geriatric population, with the number of individuals aged 60 and above projected to rise substantially.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/